title: Stupp-treated glioblastoma accompanied by EBV-positive primary CNS lymphoma.
abstract: We describe a patient who within 2 months of undergoing radio-chemotherapy for glioblastoma developed an Epstein-Barr virus-positive primary diffuse large B-cell CNS lymphoma. To our knowledge, this is the first such case reported in the literature showing that new tumefactions following aggressive treatment for glioblastomata might represent secondary malignancies.
authors: Department of Neurosurgery, Beaumont Hospital , Dublin , Ireland.
authors: Zaitun
authors: Z
authors: Zakaria
authors: Eoin
authors: E
authors: Fenton
authors: Ayman
authors: A
authors: Khalil
authors: Muhammad Taufiq
authors: MT
authors: Sattar
authors: Peter
authors: P
authors: Molnar
mesh_terms: D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000601:surgery / Q000628:therapy*; D059248:Chemoradiotherapy; D002985:Clinical Protocols; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D017809:Fatal Outcome; D005909:Glioblastoma / Q000150:complications / Q000601:surgery / Q000628:therapy*; D006261:Headache / Q000209:etiology; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications / Q000601:surgery*; D008279:Magnetic Resonance Imaging; D008297:Male; D019635:Neurosurgical Procedures / Q000379:methods*; D000077204:Temozolomide; D014057:Tomography, X-Ray Computed
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide